De Francesco, V <br/><br/>
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Feb 2004 
 - 407-14 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2036.2004.01818.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles<br/>Adult<br/>Amoxicillin--administration & dosage<br/>Anti-Bacterial Agents--administration & dosage<br/>Anti-Ulcer Agents--administration & dosage<br/>Antigens, Bacterial--genetics<br/>Bacterial Proteins--genetics<br/>Benzimidazoles--administration & dosage<br/>Clarithromycin--administration & dosage<br/>DNA--analysis<br/>Drug Evaluation<br/>Drug Therapy, Combination<br/>Dyspepsia--drug therapy<br/>Female<br/>Helicobacter Infections--drug therapy<br/>Helicobacter pylori--genetics<br/>Humans<br/>Male<br/>Middle Aged<br/>Omeprazole--analogs & derivatives<br/>Peptic Ulcer--drug therapy<br/>Polymerase Chain Reaction--methods<br/>Rabeprazole<br/>Risk Factors<br/>Smoking<br/>Tinidazole--administration & dosage<br/>Treatment Outcome